We have previously demonstrated that exposure of CLL cells to SC induces the activation of RAS/ERK1-2 and PI3K/AKT signalling pathways, leading to an upregulation of the downstream transcription factor HIF-1α [6]. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.